06 Sept 2019
A study published in the Lancet Diabetes and Endocrinology has found SGLT2 inhibitors, taken to lower blood glucose levels, prevent loss of kidney function and kidney failure in people with type 2 diabetes.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024